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Spontaneous arterial thrombosis in a patient with
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Successful treatment with pharmacomechanical
thrombectomy
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Patients with human immunodeficiency virus (HIV) have various coagulation abnormalities as well as increased risk for
development of clinical thrombosis and subsequent embolic events. We report acute lower leg ischemia caused by
spontaneous atheroembolism with no identifiable source in a young patient with HIV infection. Treatment included
percutaneous mechanical thrombectomy and thrombolysis, which reversed the arterial ischemia. Physicians should be
aware of thromboembolic disease as a possible complication of HIV. (J Vasc Surg 2003;38:392-5.)
Spontaneous atheroembolism to the lower extremities
most commonly occurs in older patients, with approxi-
mately 85% of peripheral emboli being of cardiac origin. In
younger patients, who may not have an apparent identifi-
able cause, evaluation for hematologic abnormalities and
hypercoaguability is often pursued. Increased risk for ve-
nous thromboembolism is well recognized in patients with
human immunodeficiency virus (HIV), and the disease has
been suggested to represent a pre-thrombotic state. Even
so, little exists in the literature concerning arterial throm-
boembolism causing acute ischemia in patients with HIV.
We present a case report of acute embolic occlusion of a
non-diseased popliteal artery in a 37-year-old man with
HIV infection.
CASE REPORT
A 37-year-old African American man with known HIV infec-
tion had acute left lower extremity pain. He was a cigarette smoker,
and had no history of cardiac disease; he was receiving chronic
antiretroviral therapy. After blood samples were drawn for labora-
tory studies, intravenous heparin was started. At physical examina-
tion, normal arterial pulses were present in the right (unaffected)
leg, but no pulses or Doppler signals were found below the
popliteal artery in the left leg. The left foot was cyanotic and
markedly cooler than the right foot. An electrocardiogram showed
normal sinus rhythm. Hemoglobin was 16.8 g/dL; white blood
cell count, 6900/L; and platelet count, 204,000/L. Interna-
tional normalized ratio (INR) and partial thromboplastin time
(PTT) were within normal laboratory limits.
An arteriogram demonstrated complete occlusion of the distal
popliteal artery, with delayed reconstitution of the anterior tibial
artery (Figs 1 and 2). The patient underwent percutaneous me-
chanical thrombectomy (Angiojet; Possis Medical, Minneapolis,
Minn) with an 0.018-inch system. Two units of retaplase (Cente-
cor, Alvern, PA) were added to the saline solution infusion bag.
Intravenous abciximab (Eli Lilly, Indianapolis, Ind) was begun
during the procedure, in addition to continuous heparin infusion.
Subsequently the foot was warm with strong Doppler signals,
although no pulses were palpable. The abciximab was continued
for 12 hours, and the patient was subsequently discharged with
warfarin sodium maintenance therapy.
An echocardiogram showed no thrombus, normal ventricular
function, normal valves, and no patent foramen ovale. Protein C,
protein S, lupuslike anticoagulant, antiphospholipid antibody, an-
tithrombin, activated protein C resistance, homocysteine, and PT
G202010A levels were all within normal laboratory limits. At
outpatient evaluation 1 month post-procedure, the patient had
persistent hypersensitivity of the dorsum of the foot and pain with
weight bearing. Ankle-brachial index in the affected limb was 0.91,
compared with more than 1.0 in the contralateral extremity, con-
sistent with residual thrombus. Despite slightly decreased perfu-
sion, the left foot had returned to its normal color and warmth.
DISCUSSION
This unusual case of acute limb-threatening ischemia
secondary to spontaneous arterial thrombosis in a patient
with HIV infection is distinctive in both cause and treat-
ment with percutaneous mechanical methods for rapid and
successful revascularization.
Arterial macroembolism in the lower extremities is
most commonly due to a cardiac source of embolic debris.
Patients often have a history of cardiac disease, with a
precipitating event such as atrial fibrillation, or have limb-
threatening ischemia as the initial sign of atrial myxomatous
disease. Acute thrombosis as the initial manifestation of
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Fig 1. Normal aortoiliac and superficial femoral arteries in 37-year-old patient with acute left lower limb ischemia.
Fig 2. A, Abrupt occlusion of distal popliteal artery with reconstitution of anterior tibial vessel. B, Tip of percutaneous
mechanical thrombectomy device (arrow) with improved filling of tibial branches after a few passes with the device.
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HIV infection has been reported.1 In the absence of any
identifiable source, hematologic studies are performed in
search of a hypercoagulable state.
Multiple coagulation and hematologic abnormalities
have been reported in patients infected with HIV.2 Various
cytopenias and factor deficiencies may be secondary to the
direct effects of HIV infection or occur in response to a
specific drug therapy. Hypercoagulability, opportunistic
infections, and malignancies may increase sensitivity of the
patient with HIV to thrombotic events.3 More specifically,
the occurrence of anticardiolipin antibodies, protein S de-
ficiency, antithrombin deficiency, and elevated D-dimer
levels have previously been documented in HIV- infected
patients, suggesting the presence of a pre-thrombotic state.
Documented thromboses have been described in both the
venous and arterial systems in patients with HIV, with
several series reporting as much as 10 times greater risk for
deep venous thrombosis in these patients.3,4
There is active research in search of the pathogenesis for
the hematologic abnormalities in patients with HIV. In all
probability, the mechanism is multifactorial. HIV may pro-
duce protein-wasting nephropathy or endothelial cell in-
jury, both of whichmay possibly contribute to alterations in
circulating levels of anticoagulant proteins.5 Furthermore,
reduction in CD4 cell count to less than 200 cells/mm3 has
been observed in patients with thromboembolic complica-
tions.5 The CD4 count in our patient was more than 400
cells/mm3, above the level correlated with a predisposition
to thromboembolism in other studies.5 However, as no
antecedent risk factors for arterial thrombosis were identi-
fied, we must surmise that either degree of immunosup-
pression was heightened or there existed a concurrent
opportunistic infection, neoplasm, or other inflammatory
disease, which was not apparent at presentation.
The evaluation and treatment of acute thrombosis must
be prompt and aggressive. Arteriography offers an oppor-
tunity to both localize and document the site of thrombosis
or embolism; in addition, percutaneous methods are avail-
able for rapid clot extraction. We chose to perform throm-
bus removal with a rheolytic thrombectomy catheter (An-
gioJet). We consider this to be a rapid and efficient
technique for both acutely thrombosed native leg arteries
and bypass grafts. The device works via the Venturi effect.
Rapidly flowing saline solution jets (8000 psi) are directed
backward from the tip of the device, not outward to the
vessel wall. The thrombus is drawn into the vacuum created
by these rapidly flowing jets, then out the catheter to a
collection bag. Any endothelial damage is probably from
the thrombus or from basic catheter and wire manipula-
tion. Furthermore, the AngioJet catheter enables declot-
ting of smaller, more distal vessels through one percutane-
ous access site.
Advantages of percutaneous mechanical thrombec-
tomy for treatment of acute limb ischemia have been dem-
onstrated, with initial thrombus removal rate in excess of
95%.6 Retaplase (2 units) was added to the infusion solu-
tion for the catheter. There are no data as to whether the
adjunctive tissue plasminogen activator augments clot ex-
traction. Even so, pharmacologic thrombolysis may aid in
resolving occlusion of vessels more distal to the reach of the
thrombectomy device. Nonetheless, as a result of using a
mechanical thrombectomy device, a low dose of thrombo-
lytic agent without a prolonged infusion period may have
assisted in attaining almost complete thrombus resolution.
In conclusion, this case illustrates arterial ischemia
caused by spontaneous thrombosis in a patient with HIV
infection. Whether the pathogenesis for this event was
heightened immunosuppression, an antiretroviral medica-
tion complication, or idiopathic thrombosis was not evi-
dent. The clinical diagnosis of limb-threatening ischemia
was prompt, as was intervention. Percutaneous mechanical
thrombectomy with adjunctive thrombolysis restored
lower extremity arterial circulation. The duration of neces-
sary anticoagulation is unknown, because HIV infection in
this patient may be the foremost predisposing factor to
thromboembolism. Furthermore, with increasing numbers
of patients surviving over the long term with active HIV
infection, thromboembolic complications may become
more pronounced in this population (Figs 1-3).
Fig 3. Further improvement in distal circulation with resultant
vasospasm (hourglass appearance to vessel, arrow) secondary to
guide wire and thrombectomy device passage.
JOURNAL OF VASCULAR SURGERY
August 2003394 Bush et al
REFERENCES
1. Witz M, Lehmann J, Korzets Z. Acute brachial artery thrombosis as the
initial manifestation of human immunodeficiency virus infection. Am J
Hematol 2000;64:137-9.
2. Coyle T. Management of the HIV-infected patient. Part II. Med Clin
North Am 1997;81:450-70.
3. Saber A, Aboolian A, LaRaja R, Baron H, Hanna K. HIV/AIDS and the
risk of deep venous thrombosis: a study of 45 patients with lower
extremity involvement. Am Surg 2001;67:645-7.
4. Copur A, Smith P, Gomez V, Bergman M, Homel P. HIV infection is a
risk factor for venous thromboembolism. AIDS Patient Care STDs
2002;16:205-9.
5. Saif M, Bona R, Greenberg B. AIDS and thrombosis: retrospective study of
131 HIV-infected patients. AIDS Patient Care STDS 2001;15:311-20.
6. Kasirajan K, Gray B, Beavers F, Clair D, Greenberg R, Mascha E, et al.
Rheolytic thrombectomy in the management of acute and subacute
limb-threatening ischemia. J Vasc Interv Radiol 2001;12:413-21.
Submitted Dec 17, 2002; accepted Jan 30, 2003.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 2 Bush et al 395
